Basolateral chloride transporters in autosomal dominant polycystic kidney disease

被引:27
|
作者
Lebeau, C
Hanaoka, K
Moore-Hoon, ML
Guggino, WB
Beauwens, R
Devuyst, O
机构
[1] Catholic Univ Louvain, Div Nephrol, B-1200 Brussels, Belgium
[2] Free Univ Brussels, Dept Phytopathol, Brussels, Belgium
[3] Johns Hopkins Univ, Sch Med, Dept Physiol, Bethesda, MD USA
[4] NIDCD, NIH, Bethesda, MD USA
来源
关键词
ADPKD; anion exchanger; CFTR; chloride channel; renal cyst; sodium-potassium-chloride cotransporter;
D O I
10.1007/s00424-002-0880-3
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Transepithelial Cl- secretion mediated by apical cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channels plays a key role in cyst fluid accumulation in autosomal dominant polycystic kidney disease (ADPKD). The molecular identity of the basolateral transporter(s) responsible for Cl- entry in ADPKD cells is unknown, although pharmacological studies suggest that a bumetanide-sensitive Na+-K+-2Cl(-) cotransporter (NKCC/BSC) is involved. We investigated the expression of NKCC1, CFTR and anion exchanger type I (AE1) in ADPKD kidneys and cultured ADPKD cells. Immunoblotting and immunoprecipitation detected NKCC1 at similar to170 kDa in ADPKD cells and kidney extracts. Immunostaining located NKCC1 in one-third of ADPKD cysts, with a pattern of basolateral reactivity. Staining of serial sections showed that cysts positive for NKCC1 also stained for CFTR. Additional studies demonstrated that AE1 is expressed in ADPKD kidneys, and is located at the basolateral pole of CFTR-positive ADPKD cysts that do not express NKCC1. RT-PCR and sequence analyses confirmed the selective expression of NKCC1 or AEI in cultured ADPKD cells that also express CFTR. The fact that most CFTR-positive ADPKD cysts also express NKCC1 suggests that transepithelial Cl- secretion in ADPKD involves molecular mechanisms similar to secretory epithelia. AE1 might be an alternative basolateral pathway for Cl- in a minority of cysts.
引用
收藏
页码:722 / 731
页数:10
相关论文
共 50 条
  • [21] Autosomal Dominant Polycystic Kidney Disease
    Srivastava, Ajay
    Patel, Neel
    AMERICAN FAMILY PHYSICIAN, 2014, 90 (05) : 303 - 307
  • [22] Autosomal Dominant Polycystic Kidney Disease
    Ekser, Burcin
    Rigotti, Paolo
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01): : 71 - 71
  • [23] Destabilization of the basolateral cargo delivery site and impaired basolateral trafficking in autosomal dominant polycystic kidney disease.
    Charron, A
    Bacallao, R
    Wandinger-Ness, A
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 410A - 410A
  • [24] Pregnancy in Autosomal Dominant Polycystic Kidney Disease
    Al Sayyab, Mina
    Chapman, Arlene
    ADVANCES IN KIDNEY DISEASE AND HEALTH, 2023, 30 (05): : 454 - 460
  • [25] Autosomal-dominant polycystic kidney disease
    Thomas, Merlin C.
    NEPHROLOGY, 2007, 12 : S52 - S56
  • [26] AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE
    LIESKE, JC
    TOBACK, FG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1993, 3 (08): : 1442 - 1450
  • [27] Choledocholithiasis in autosomal dominant polycystic kidney disease
    Sachdeva, Sanjeev
    Sethi, Sukrit Singh
    Kumar, Ajay
    Dalal, Ashok
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (01) : 127 - 128
  • [28] AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE
    REEDERS, S
    QUARTERLY JOURNAL OF MEDICINE, 1991, 79 (290): : 459 - 460
  • [29] Epigenetics and autosomal dominant polycystic kidney disease
    Li, Xiaogang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (10): : 1213 - 1218
  • [30] Autophagy and Autosomal Dominant Polycystic Kidney Disease
    Oto, Ozgur Akin
    Edelstein, Charles L.
    TURKISH JOURNAL OF NEPHROLOGY, 2023, 32 (01): : 8 - 15